News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,468 Results
Type
Article (31955)
Company Profile (12)
Press Release (143501)
Multimedia
Podcasts (9)
Webinars (10)
Section
Business (51969)
Career Advice (364)
Deals (3217)
Drug Delivery (11)
Drug Development (23824)
Employer Resources (32)
FDA (3345)
Job Trends (3177)
News (80353)
Policy (4193)
Tag
Academia (2411)
Academic (1)
Accelerated approval (6)
Adcomms (9)
Allergies (35)
Alliances (10860)
ALS (48)
Alzheimer's disease (600)
Antibody-drug conjugate (ADC) (45)
Approvals (3445)
Artificial intelligence (112)
Autoimmune disease (28)
Automation (7)
Bankruptcy (17)
Best Places to Work (2658)
BIOSECURE Act (3)
Biosimilars (13)
Biotechnology (12)
Bladder cancer (36)
Brain cancer (26)
Breast cancer (181)
Cancer (1315)
Cardiovascular disease (90)
Career advice (341)
Career pathing (9)
CAR-T (77)
CDC (19)
Cell therapy (191)
Cervical cancer (9)
Clinical research (19520)
Collaboration (315)
Company closure (1)
Compensation (23)
Complete response letters (6)
COVID-19 (1198)
CRISPR (28)
C-suite (530)
Cystic fibrosis (32)
Data (2011)
Decentralized trials (1)
Denatured (6)
Depression (36)
Diabetes (119)
Diagnostics (1727)
Digital health (4)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (49)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (6548)
Editorial (8)
Employer branding (2)
Employer resources (30)
Events (18444)
Executive appointments (620)
FDA (3905)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (388)
Gene editing (58)
Generative AI (5)
Gene therapy (132)
GLP-1 (163)
Government (988)
Guidances (24)
Healthcare (5037)
HIV (14)
Huntington's disease (6)
IgA nephropathy (24)
Immunology and inflammation (22)
Immuno-oncology (12)
Indications (19)
Infectious disease (1262)
Inflammatory bowel disease (53)
Inflation Reduction Act (1)
Influenza (36)
Intellectual property (36)
Interviews (41)
IPO (1456)
IRA (8)
Job creations (576)
Job search strategy (316)
JPM (4)
Kidney cancer (7)
Labor market (16)
Layoffs (38)
Leadership (5)
Legal (684)
Liver cancer (26)
Longevity (2)
Lung cancer (148)
Lymphoma (120)
Machine learning (10)
Management (9)
Manufacturing (94)
MASH (59)
Medical device (3113)
Medtech (3123)
Mergers & acquisitions (1851)
Metabolic disorders (248)
Multiple sclerosis (40)
NASH (5)
Neurodegenerative disease (92)
Neuropsychiatric disorders (11)
Neuroscience (918)
Neurotech (1)
NextGen: Class of 2026 (1795)
Non-profit (1719)
Now hiring (6)
Obesity (64)
Opinion (37)
Ovarian cancer (62)
Pain (40)
Pancreatic cancer (71)
Parkinson's disease (84)
Partnered (6)
Patents (69)
Patient recruitment (131)
Peanut (14)
People (33257)
Phase 1 (6173)
Phase 2 (8938)
Phase 3 (5977)
Pipeline (881)
Policy (51)
Postmarket research (955)
Preclinical (3155)
Press Release (25)
Prostate cancer (68)
Psychedelics (10)
Radiopharmaceuticals (75)
Rare diseases (173)
Real estate (1288)
Recruiting (16)
Regulatory (3349)
Reports (4)
Research institute (1381)
Resumes & cover letters (23)
Rett syndrome (4)
RNA editing (3)
RSV (5)
Schizophrenia (29)
Series A (59)
Series B (31)
Sickle cell disease (27)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (1114)
Stomach cancer (1)
Supply chain (1)
Tariffs (7)
The Weekly (3)
Vaccines (277)
Venture capital (12)
Weight loss (37)
Women's health (20)
Worklife (2)
Date
Today (16)
Last 7 days (103)
Last 30 days (381)
Last 365 days (6187)
2026 (543)
2025 (6294)
2024 (7448)
2023 (9214)
2022 (11452)
2021 (13197)
2020 (12733)
2019 (12111)
2018 (8989)
2017 (8671)
2016 (8865)
2015 (10194)
2014 (7788)
2013 (7568)
2012 (7527)
2011 (7540)
2010 (6760)
Location
Africa (262)
Alabama (15)
Alaska (3)
Arizona (53)
Arkansas (6)
Asia (10697)
Australia (2666)
California (2352)
Canada (665)
China (245)
Colorado (100)
Connecticut (89)
Delaware (61)
Europe (28430)
Florida (296)
Georgia (83)
Idaho (13)
Illinois (183)
India (6)
Indiana (92)
Iowa (9)
Japan (108)
Kansas (19)
Kentucky (6)
Louisiana (7)
Maine (16)
Maryland (265)
Massachusetts (1578)
Michigan (52)
Minnesota (110)
Mississippi (4)
Missouri (37)
Montana (6)
Nebraska (5)
Nevada (20)
New Hampshire (12)
New Jersey (642)
New Mexico (8)
New York (659)
North Carolina (366)
North Dakota (3)
Northern California (1223)
Ohio (99)
Oklahoma (8)
Oregon (9)
Pennsylvania (447)
Puerto Rico (4)
Rhode Island (15)
South America (289)
South Carolina (11)
Southern California (865)
Tennessee (46)
Texas (387)
United States (8250)
Utah (71)
Virginia (56)
Washington D.C. (19)
Washington State (201)
West Virginia (2)
Wisconsin (26)
175,468 Results for "georgetown university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors
KeifeRx announced entry into an amended exclusive licensing agreement with Georgetown University to advance the development of novel tyrosine kinase inhibitor chemical entities for the treatment of multiple disease indications.
January 8, 2024
·
3 min read
BioMidwest
Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights to Intellectual Property From Georgetown University for Azeliragon as a Potential Treatment of Cancer-Related Cognitive Decline
Cantex Pharmaceuticals, Inc. announced that it has obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer-treatment related cognitive decline.
June 1, 2023
·
4 min read
Bio NC
vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline
vTv Therapeutics Inc. announced that Cantex Pharmaceuticals, Inc. recently obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer treatment-related cognitive decline.
June 16, 2023
·
5 min read
BioCapital
Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) today announced it has entered a research agreement with Georgetown University focused on the evaluation of the Company’s lead HDAC6 inhibitor candidate, SP-2-225, evaluating the anti-tumor effect of the combination of SP-2-225 and RT in a syngeneic breast cancer model.
March 22, 2023
·
4 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Press Releases
Tolmar Opens Northern Illinois Laboratory at Rosalind Franklin University’s Innovation and Research Park
December 16, 2025
·
1 min read
Press Releases
Charles River Enters Manufacturing Collaboration with Gazi University
January 21, 2026
·
2 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
Business
Padma Doniparthi, MD, DABA, DABPM, AAHPC, Joins Pain Specialists of America in Temple and Georgetown, TX
Pain Specialists of America is pleased to announce that Padma Doniparthi, MD, DABA, DABPM, AAHPC, has joined their team to provide patient care in their Temple and Georgetown, Texas communities.
September 6, 2022
·
3 min read
1 of 17,547
Next
